William Rose

Insider Reports History

Entity
Individual
Location
300 Crescent Court, Suite 700, Dallas, TX
Signature
/s/ Charles E. Gale, Attorney-In-Fact for William E. Rose
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Rose:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 Sep 26, 2023 By trust
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director Class A common stock 0 $172.03 Sep 26, 2023 Indirect
REATA PHARMACEUTICALS INC Director Class B Common Stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Director Class B Common Stock 0 $172.03 Sep 26, 2023 Indirect
REATA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 Sep 26, 2023 Direct

Insider Reports Filed by William Rose

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 31 $0 4 Sep 26, 2023 Director
RETA REATA PHARMACEUTICALS INC Sep 15, 2023 8 $0 4 Sep 19, 2023 Director
RETA REATA PHARMACEUTICALS INC Aug 23, 2023 1 $0 4 Aug 24, 2023 Director
RETA REATA PHARMACEUTICALS INC Jun 7, 2023 2 $79.9K 4 Jun 9, 2023 Director, Member of 10% owner group, 10%+ Owner
RETA REATA PHARMACEUTICALS INC Jun 8, 2022 2 $80K 4 Jun 10, 2022 Director, Member of 10% owner group, 10%+ Owner
RETA REATA PHARMACEUTICALS INC Jun 10, 2021 2 $67.4K 4 Jun 14, 2021 Director, Member of 10% owner group, 10%+ Owner